BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26249360)

  • 1. LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway.
    Luo Q; Wang C; Jin G; Gu D; Wang N; Song J; Jin H; Hu F; Zhang Y; Ge T; Huo X; Chu W; Shu H; Fang J; Yao M; Gu J; Cong W; Qin W
    Carcinogenesis; 2015 Oct; 36(10):1201-12. PubMed ID: 26249360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients.
    Wang RY; Chen L; Chen HY; Hu L; Li L; Sun HY; Jiang F; Zhao J; Liu GM; Tang J; Chen CY; Yang YC; Chang YX; Liu H; Zhang J; Yang Y; Huang G; Shen F; Wu MC; Zhou WP; Wang HY
    Gastroenterology; 2013 Dec; 145(6):1436-48.e1-12. PubMed ID: 23933603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma.
    Wang C; Jin G; Jin H; Wang N; Luo Q; Zhang Y; Gao D; Jiang K; Gu D; Shen Q; Huo X; Hu F; Ge T; Zhao F; Chu W; Shu H; Yao M; Cong W; Qin W
    Oncotarget; 2015 Feb; 6(5):2903-16. PubMed ID: 25609201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients.
    Huang CY; Huang XP; Zhu JY; Chen ZG; Li XJ; Zhang XH; Huang S; He JB; Lian F; Zhao YN; Wu GB
    Oncol Rep; 2015 Jun; 33(6):2889-98. PubMed ID: 25962360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma.
    Hsieh SY; He JR; Hsu CY; Chen WJ; Bera R; Lin KY; Shih TC; Yu MC; Lin YJ; Chang CJ; Weng WH; Huang SF
    Hepatology; 2011 Feb; 53(2):504-16. PubMed ID: 21246584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin G1-mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase/Akt signaling facilitates liver cancer progression.
    Wen W; Ding J; Sun W; Fu J; Chen Y; Wu K; Ning B; Han T; Huang L; Chen C; Xie D; Li Z; Feng G; Wu M; Xie W; Wang H
    Hepatology; 2012 Jun; 55(6):1787-98. PubMed ID: 22271581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array.
    Okamura Y; Nomoto S; Kanda M; Li Q; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A
    Cancer Lett; 2010 Mar; 289(2):170-7. PubMed ID: 19733004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)‑2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway.
    Li X; Yang Z; Song W; Zhou L; Li Q; Tao K; Zhou J; Wang X; Zheng Z; You N; Dou K; Li H
    Int J Oncol; 2013 Sep; 43(3):793-802. PubMed ID: 23807724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slit2 and Robo1 induce opposing effects on metastasis of hepatocellular carcinoma Sk-hep-1 cells.
    Yuan M; Guo H; Li J; Sui C; Qin Y; Wang J; Khan YH; Ye L; Xie F; Wang H; Yuan L; Ye J
    Int J Oncol; 2016 Jul; 49(1):305-15. PubMed ID: 27176045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tropomodulin 3 modulates EGFR-PI3K-AKT signaling to drive hepatocellular carcinoma metastasis.
    Zheng H; Yang Y; Hong YG; Wang MC; Yuan SX; Wang ZG; Bi FR; Hao LQ; Yan HL; Zhou WP
    Mol Carcinog; 2019 Oct; 58(10):1897-1907. PubMed ID: 31313392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of microRNA-133b is associated with the increased survival of patients with hepatocellular carcinoma after curative hepatectomy: Involvement of the EGFR/PI3K/Akt/mTOR signaling pathway.
    Wang X; Zeng J; Wang L; Zhang X; Liu Z; Zhang H; Dong J
    Oncol Rep; 2017 Jul; 38(1):141-150. PubMed ID: 28586051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rab31 promoted hepatocellular carcinoma (HCC) progression via inhibition of cell apoptosis induced by PI3K/AKT/Bcl-2/BAX pathway.
    Sui Y; Zheng X; Zhao D
    Tumour Biol; 2015 Nov; 36(11):8661-70. PubMed ID: 26044564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MACC1 suppresses cell apoptosis in hepatocellular carcinoma by targeting the HGF/c-MET/AKT pathway.
    Yao Y; Dou C; Lu Z; Zheng X; Liu Q
    Cell Physiol Biochem; 2015; 35(3):983-96. PubMed ID: 25660117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [EEF1A2 inhibits the p53 function in hepatocellular carcinoma via PI3K/AKT/mTOR-dependent stabilization of MDM4].
    Longerich T
    Pathologe; 2014 Nov; 35 Suppl 2():177-84. PubMed ID: 25394965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma.
    Fu SJ; Shen SL; Li SQ; Hua YP; Hu WJ; Guo B; Peng BG
    BMC Cancer; 2018 Aug; 18(1):815. PubMed ID: 30103712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
    Fang Y; Xue JL; Shen Q; Chen J; Tian L
    Hepatology; 2012 Jun; 55(6):1852-62. PubMed ID: 22234835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.